Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 9/2008

01-09-2008 | Healthcare Policy and Outcomes

The Role of Health-Related Quality of Life Outcomes in Clinical Decision Making in Surgery for Esophageal Cancer: A Systematic Review

Authors: R. Parameswaran, MRCS, A. McNair, MRCS, K. N. L. Avery, PhD, R. G. Berrisford, FRCS (Th), S. A. Wajed, MCRir, FRCS, M. A. G. Sprangers, PhD, J. M. Blazeby, MD, FRCS

Published in: Annals of Surgical Oncology | Issue 9/2008

Login to get access

Abstract

Background

Esophagectomy for cancer offers a chance of cure but is associated with morbidity, at least a temporary reduction in health-related quality of life (HRQL), and a 5-year survival of approximately 30%. This research evaluated how and whether HRQL outcomes contribute to surgical decision making.

Methods

A systematic review identified randomized trials and longitudinal and cross-sectional studies that assessed HRQL after esophagectomy with multidimensional validated questionnaires. Articles were independently evaluated by two reviewers, and the value of HRQL in clinical decision making was categorized in three ways: (1) the assessment of the quality of HRQL methodology according to predefined criteria; (2) the influence of HRQL outcomes on treatment recommendations and/or informed consent; and (3) the HRQL after esophagectomy for cancer in methodologically robust studies.

Results

Eighteen publications were identified, of which 16 (89%) were categorized as having robust HRQL design. Of these studies, 3 concluded that HRQL influenced treatment recommendations and 11 (including the former 3) informed patient consent. The remaining five papers were well designed, but the authors did not use HRQL to influence treatment recommendations or informed consent. After esophagectomy, patients report major deterioration in most aspects of HRQL with slow recovery.

Conclusion

HRQL outcomes are relevant to surgical decision making. Methods to communicate HRQL outcomes to patients are required to inform consent and clinical practice.
Literature
1.
Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002; 347:1662–9.PubMedCrossRef
2.
Jamieson GG, Mathew G, Ludemann R, et al. Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg 2004; 91:943–7.PubMedCrossRef
3.
Portale G, Hagen JA, Peters JH, et al. Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients. J Am Coll Surg 2006; 202:588–96.PubMedCrossRef
4.
Altorki N, Skinner D. Should en bloc esophagectomy be the standard of care for esophageal carcinoma? Ann Surg 2001; 234:581–7.PubMedCrossRef
5.
Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemothearpy in oesophageal cancer. Lancet 2002; 359:1727–33.CrossRef
6.
US Food and Drug Administration. Guidance for industry. Patient-reported outcome measures: use in medical product development for labeling claims. Rockville, MD: US Food and Drug Administration; 2006. p. 1–32.
7.
Stahl M, Stuschke M, Lehmann N, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005; 23:2310–7.PubMedCrossRef
8.
Urba SG, Orringer MB, Turrisi A, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001; 19:305–13.PubMed
9.
Goodwin PJ, Black JT, Bordeleau LJ, et al. Health-related quality-of-life measurement in randomized clinical trials in breast cancer—taking stock. J Natl Cancer Inst 2003; 95:263–81.PubMedCrossRef
10.
Efficace F, Bottomley A, Osoba D, et al. Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials—does HRQOL evaluation in prostate cancer research inform clinical decision making? J Clin Oncol 2003; 21:3502–11.PubMedCrossRef
11.
Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30:473–83.PubMedCrossRef
12.
Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85:365–76.PubMedCrossRef
13.
de Haes JCJM, Olschewski M, Fayers PM, et al. Measuring the quality of life of cancer patients: the Rotterdam symptom checklist (RSCL): a manual. Groningen, The Netherlands: Northern Centre for Healthcare Research, 1996
14.
Luketich JD, Velo-Rivera M, Buenaventura PO, et al. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg 2003; 238:486–94.PubMed
15.
O’Hanlon DM, Harkin M, Karat D, et al. Quality-of-life assessment in patients undergoing treatment for oesophageal carcinoma. Br J Surg 1995; 82:1682–5.PubMedCrossRef
16.
Zieren HU, Jacobi CA, Zieren J, et al. Quality of life following resection of oesophageal carcinoma. Br J Surg 1996; 83:1772–5.PubMedCrossRef
17.
Blazeby JM, Farndon JR, Donovan J, et al. A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 2000; 88:1781–7.PubMedCrossRef
18.
Brooks JA, Kesler KA, Johnson CS, et al. Prospective analysis of quality of life after surgical resection for esophageal cancer: preliminary results. J Surg Oncol 2002; 81:185–94.PubMedCrossRef
19.
de Boer AG, van Lanschot JJ, van Sandick JW, et al. Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol 2004; 22:4202–8.PubMedCrossRef
20.
Blazeby JM, Sanford E, Falk SJ, et al. Health-related quality of life during neoadjuvant treatment and surgery for localized esophageal carcinoma. Cancer 2005; 103:1791–9.PubMedCrossRef
21.
Bonnetain F, Bouche O, Michel P, et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Ann Oncol 2006; 17:827–34.PubMedCrossRef
22.
Cense HA, Hulscher JB, de Boer AG, et al. Effects of prolonged intensive care unit stay on quality of life and long-term survival after transthoracic esophageal resection. Crit Care Med 2006; 34:354–62.PubMedCrossRef
23.
Reynolds JV, McLaughlin R, Moore J, et al. Prospective evaluation of quality of life in patients with localized oesophageal cancer treated by multimodality therapy or surgery alone. Br J Surg 2006; 93:1084–90.PubMedCrossRef
24.
van Knippenberg FC, Out JJ, Tilanus HW, et al. Quality of Life in patients with resected oesophageal cancer. Soc Sci Med 1992; 35:139–45.PubMedCrossRef
25.
McLarty AJ, Deschamps C, Trastek VF, et al. Esophageal resection for cancer of the esophagus: long-term function and quality of life. Ann Thorac Surg 1997; 63:1568–72.PubMedCrossRef
26.
Hallas CN, Patel N, Oo A, et al. Five-year survival following oesophageal cancer resection: psychosocial functioning and quality of life. Psychol Health Med 2001; 6:84–94.CrossRef
27.
Headrick JR, Nichols FC III, Miller DL, et al. High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy. Ann Thorac Surg 2002; 73:1697–702.PubMedCrossRef
28.
Schmidt CE, Bestmann B, Kuchler T, et al. Quality of life associated with surgery for esophageal cancer: differences between collar and intrathoracic anastomoses. World J Surg 2004; 28:355–60.PubMedCrossRef
29.
Viklund P, Lindblad M, Lagergren J. Influence of surgery-related factors on quality of life after esophageal or cardia cancer resection. World J Surg 2005; 29:841–8.PubMedCrossRef
30.
Viklund P, Wengstrom Y, Rouvelas I, et al. Quality of life and persisting symptoms after oesophageal cancer surgery. Eur J Cancer 2006; 42:1407–14.PubMedCrossRef
31.
Cense HA, Visser MR, van Sandick JW, et al. Quality of life after colon interposition by necessity for esophageal cancer replacement. J Surg Oncol 2004; 88:32–8.PubMedCrossRef
32.
Leibman S, Smithers BM, Gotley DC, et al. Minimally invasive esophagectomy: short- and long-term outcomes. Surg Endosc 2006; 20:428–33.PubMedCrossRef
33.
de Boer AG, Genovesi PI, Sprangers MA, et al. Quality of life in long-term survivors after curative transhiatal oesophagectomy for oesophageal carcinoma. Br J Surg 2000; 87:1716–21.PubMedCrossRef
34.
Spector NM, Hicks FD, Pickleman J. Quality of life and symptoms after surgery for gastroesophageal cancer: a pilot study. Gastroenterol Nurs 2002; 25:120–5.PubMedCrossRef
35.
Blazeby JM, Nicklin J, Brookes ST, et al. Feasibility of quality of life assessment in patients with upper gastrointestinal tract cancer. Br J Cancer 2003; 89:497–501.PubMedCrossRef
36.
Blazeby JM, Avery K, Sprangers M, et al. Health-related quality of life measurement in randomized clinical trials in surgical oncology. J Clin Oncol 2006; 24:3178–86.PubMedCrossRef
37.
Lagergren P, Avery KN, Hughes R, et al. Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer 2007; 110:686–93.PubMedCrossRef
38.
Medical Defence Union. Consent to Treatment. London: MDU, 2004
39.
Gore DM. Ethical, professional, and legal obligations in clinical practice: a series of discussion topics for postgraduate medical education. Introduction and topic 1: informed consent. Postgrad Med J 2001; 77:238–9.PubMedCrossRef
40.
41.
Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998; 16:139–44.PubMed
42.
King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 1996; 5:555–67.PubMedCrossRef
43.
Gradauskas P, Rubikas R, Saferis V. Changes in quality of life after esophageal resections for carcinoma. Medicina (Kaunas) 2006; 42:187–94.
Metadata
Title
The Role of Health-Related Quality of Life Outcomes in Clinical Decision Making in Surgery for Esophageal Cancer: A Systematic Review
Authors
R. Parameswaran, MRCS
A. McNair, MRCS
K. N. L. Avery, PhD
R. G. Berrisford, FRCS (Th)
S. A. Wajed, MCRir, FRCS
M. A. G. Sprangers, PhD
J. M. Blazeby, MD, FRCS
Publication date
01-09-2008
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 9/2008
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-008-0042-8

Other articles of this Issue 9/2008

Annals of Surgical Oncology 9/2008 Go to the issue

Gastrointestinal Oncology

Lumboaortic and Iliac Lymphadenectomy for Lymph Node Recurrence of Colorectal Cancer: Prognostic Value of the MSI Phenotype

Radiation Oncology

Benefits, Limitations, and Harm of Local Excision for Rectal Cancer

Endocrine Tumors

Role of Surgeon-Performed Ultrasound in Predicting Malignancy in Patients with Indeterminate Thyroid Nodules

Breast Oncology

Combined Axillary Reverse Mapping (ARM) Technique for Breast Cancer Patients Requiring Axillary Dissection

Gastrointestinal Oncology

Stage-Specific Guided Adjuvant Treatment for Gastric Cancer

Gastrointestinal Oncology

Extra-Intestinal Manifestations of Familial Adenomatous Polyposis